- Previous Close
0.4600 - Open
0.5150 - Bid 0.4900 x 137600
- Ask 0.5800 x 131100
- Day's Range
0.5150 - 0.5150 - 52 Week Range
0.4740 - 0.7550 - Volume
50 - Avg. Volume
0 - Market Cap (intraday)
693.849M - Beta (5Y Monthly) 1.05
- PE Ratio (TTM)
10.30 - EPS (TTM)
0.0500 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield 0.02 (4.56%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
--
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and internationally. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the wholesale and retail sale of Chinese medicines and healthcare products; technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; and internal and external surgery, medical examination, and traditional Chinese medicine department and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People's Republic of China.
www.tongrentangkj.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TNG.F
View MorePerformance Overview: TNG.F
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TNG.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TNG.F
View MoreValuation Measures
Market Cap
678.20M
Enterprise Value
433.00M
Trailing P/E
8.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.65
Price/Book (mrq)
0.65
Enterprise Value/Revenue
0.48
Enterprise Value/EBITDA
3.07
Financial Highlights
Profitability and Income Statement
Profit Margin
7.19%
Return on Assets (ttm)
4.41%
Return on Equity (ttm)
8.95%
Revenue (ttm)
7.26B
Net Income Avi to Common (ttm)
521.8M
Diluted EPS (ttm)
0.0500
Balance Sheet and Cash Flow
Total Cash (mrq)
4.38B
Total Debt/Equity (mrq)
23.86%
Levered Free Cash Flow (ttm)
--